So here's the situation confronting the drug firms: The…
“So here's the situation confronting the drug firms: The drugs cost more to make, but they can't charge more for them. What do they do? Increasingly, the U.S. market is driving them toward drugs aimed at the diseases of richer, older Americans and away from antimicrobials, vaccines, and the like.”
About This Quote
This interpretation was drafted with AI assistance. It is one reading of the quote, not the author's own explanation.
Pharma firms face pressure to prioritize profitable markets, shifting away from low‑margin essential drugs like vaccines.
In simple terms: Companies chase profit, neglecting public health needs.
Key Takeaway
Consider balancing profit with societal benefit.
Themes
pharma economics
public health
market incentives
Mood
concerned
critical
Type
analytical
policy
When to use this quote
- policy making
- healthcare budgeting
- corporate strategy
Key Concepts
profit motive
access to medicine
R&D allocation
Questions to Reflect On
- How can incentives be realigned?
- What role should regulation play?
A Different Perspective
Profit focus can limit innovation for underserved diseases.